# Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics

> **NCT02682862** · PHASE4 · COMPLETED · sponsor: **University of Dundee** · enrollment: 17 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** olodaterol hydrochloride 2.5mcg, tiotropium bromide 2.5mcg
- **DRUG:** olodaterol 2.5 mcg

## Key facts

- **NCT ID:** NCT02682862
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-11
- **Primary completion:** 2019-05-22
- **Final completion:** 2019-05-22
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682862, "Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02682862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*